Tatva Chintan Pharma - Quaterly Results

24 Jan 2023 Evaluate
A fair growth of 11.76% in the revenue at Rs. 1135.37 millions was reported in the December 2022 quarter as compared to Rs. 1015.92 millions during year-ago period.Net profit of the cmpany stood at Rs. 105.57 millions for the quarter ended December 2022 a decline of -52.93% from Rs. 224.28 millions  in the same quarter last year.A decline of 179.20 millions was observed in the OP in the quarter ended December 2022 from 278.39 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 1135.37 1015.92 11.76 2836.40 3259.31 -12.98 4278.11 2911.88 46.92
Other Income 10.73 50.81 -78.88 44.51 92.46 -51.86 105.06 50.98 106.08
PBIDT 179.20 278.39 -35.63 437.28 929.88 -52.97 1162.77 702.85 65.44
Interest 23.84 9.88 141.30 47.61 36.51 30.40 48.32 42.07 14.86
PBDT 155.36 268.51 -42.14 389.67 893.37 -56.38 1114.45 660.78 68.66
Depreciation 23.83 20.76 14.79 70.24 60.31 16.46 81.80 67.30 21.55
PBT 131.53 247.75 -46.91 319.43 833.06 -61.66 1032.65 593.48 74.00
TAX 25.96 23.47 10.61 76.30 62.04 22.99 72.79 79.89 -8.89
Deferred Tax 4.59 -24.51 -118.73 12.12 -83.05 -114.59 -107.29 -23.77 351.37
PAT 105.57 224.28 -52.93 243.13 771.02 -68.47 959.86 513.59 86.89
Equity 221.65 221.65 0.00 221.65 221.65 0.00 221.65 200.88 10.34
PBIDTM(%) 15.78 27.40 -42.40 15.42 28.53 -45.96 27.18 24.14 12.60

Tatva Chintan Pharma Share Price

1387.00 -31.50 (-2.22%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
BASF India 4039.90
Tata Chemicals 773.85
SRF 2886.20
Pidilite Inds. 1474.70
Deepak Nitrite 1565.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×